Daniel Alkon is the founder of Synaptogenix. Alkon is the President and Chief Science Officer (CSO) at Synaptogenix.
Daniel L. Alkon is the President and Chief Science Officer (CSO) at Synaptogenix, a clinical-stage biopharmaceutical company. He is responsible for leading the company's scientific strategy to develop restorative therapeutics for neurodegenerative diseases and developmental disorders.
Full founder directory · Investor directory · Company funding database · Fundraising library